ストックスクリーナーアプリを入手
237.57
0.58%
-1.39
前日終値:
$238.96
開ける：
$237.79
24時間の取引高:
1.03M
Relative Volume:
0.66
時価総額：
$55.01B
収益：
$250.74B
当期純損益:
$1.55B
株価収益率:
36.33
EPS:
6.5398
ネットキャッシュフロー:
$4.39B
1週間 パフォーマンス:
+1.91%
1か月 パフォーマンス:
+1.28%
6か月 パフォーマンス:
+10.23%
1年 パフォーマンス:
+51.43%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$230.61
$241.96
52週間の値動き範囲:
$151.87
$258.30
Cardinal Health Inc Stock (CAH) Company Profile
Compare CAH vs MCK, COR, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
237.57 | 55.01B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
938.84 | 109.46B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
323.85 | 61.80B | 328.68B | 2.55B | 1.56B | 13.03 |
HSIC
Henry Schein Inc
|
84.01 | 9.36B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.25 | 1.07B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-08-19 | 開始されました | RBC Capital Mkts | Outperform |
| 2026-04-28 | 開始されました | William Blair | Outperform |
| 2026-01-09 | アップグレード | Citigroup | Neutral → Buy |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-06-03 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | アップグレード | Jefferies | Hold → Buy |
| 2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
| 2025-01-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-01-06 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-12-13 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | 再開されました | Mizuho | Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-02-09 | アップグレード | Argus | Hold → Buy |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Underweight |
| 2023-07-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-03-31 | 開始されました | Citigroup | Neutral |
| 2023-02-03 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-08-22 | 再開されました | Morgan Stanley | Overweight |
| 2022-05-26 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2022-05-18 | アップグレード | Evercore ISI | In-line → Outperform |
| 2022-04-12 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | 再開されました | Credit Suisse | Neutral |
| 2021-08-06 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-08-05 | ダウングレード | BofA Securities | Buy → Underperform |
| 2021-05-10 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-09-25 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-07-20 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-05-15 | アップグレード | UBS | Neutral → Buy |
| 2020-04-23 | 再開されました | Credit Suisse | Neutral |
| 2020-03-20 | アップグレード | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-08-27 | ダウングレード | Argus | Buy → Hold |
| 2019-08-20 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-04-18 | 開始されました | Guggenheim | Neutral |
| 2019-01-17 | 開始されました | UBS | Neutral |
| 2018-11-16 | ダウングレード | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | アップグレード | Argus | Hold → Buy |
| 2018-03-08 | 開始されました | Barclays | Equal Weight |
| 2018-02-27 | 再開されました | BofA/Merrill | Underperform |
| 2018-01-05 | 開始されました | Evercore ISI | In-line |
すべてを表示
Cardinal Health Inc (CAH) 最新ニュース
China Patient Examination Devices Market Size, Share, and Forecast to 2033Thermometers and Stethoscopes | Pricing Trends and Growth Opportunities Guide Expansion - GlobeNewswire Inc.
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - Zacks Investment Research
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Freehand CEO Nitin Jayakrishnan Addresses Supply Chain Disruption and Resilience at LogiPharma USA 2026 - GlobeNewswire Inc.
Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know - Zacks Investment Research
Cardinal Health stock gains 1.59 percent after CVS pact - AD HOC NEWS
Cardinal Health, Inc. (CAH) Stock Forecasts - Yahoo! Finance Canada
Cardinal Health agrees to extend CVS deal: Cardinal Health stock gains 1.33 percent - AD HOC NEWS
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex - Zacks Investment Research
CVS renews as Cardinal Health’s largest customer through 2032 - bizjournals.com
Is Cardinal Health Inc (CAH) Overvalued After 3.4% Rally? GF Val - gurufocus.com
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health, Inc. (CAH) Stock Forecasts - Yahoo Finance
Cardinal Health, Inc. (CAH) Stock Forecasts - Yahoo! Finance Canada
Cardinal Health rises on extended CVS distribution deal - Investing.com
Cardinal Health, McKesson Extend Distribution Pacts With CVS Through 2032 - finance.biggo.com
McKesson and Cardinal Health: CVS Contract Renewal Reaffirms Narrow Moat and Long-Term Growth - Morningstar
Why Is Cardinal Health and McKesson Stock Trading Higher TodayCVS Health (NYSE:CVS), McKesson (NYSE:MC - Benzinga
Why Is Cardinal Health and McKesson Stock Trading Higher TodayCVS Health (NYSE:CVS), McKesson (NYSE:MC - Benzinga
Cardinal Health renews contract with CVS Health - marketscreener.com
Cardinal Health Extends CVS Health Pharmaceutical Distribution Agreement Through 2032 - Yahoo Finance
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve - Zacks Investment Research
Cardinal Health (CAH) Extends CVS Distribution Deal Through 2032, Reaffirms FY2027 EPS Guidance - gurufocus.com
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health - Yahoo Finance
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5 - Yahoo! Finance Canada
Cardinal Health: I'm Still Buying After Checking The Numbers (NYSE:CAH) - Seeking Alpha
Total debt per share of Cardinal Health, Inc. – HAN:CLH - TradingView
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings? - The Globe and Mail
At-Home Healthcare Is Growing Fast: Can CAH Ride the Trend? - TradingView
Cardinal Health stock at USD 220.22 on September 25, 2026 - AD HOC NEWS
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Cardinal Health Inc. stock underperforms Friday when compared to competitors - MarketWatch
Cardinal Health vs. McKesson: Which Healthcare Stock Is Better? - Yahoo Finance
Cardinal Health (CAH) Stock Moves -1.64%: What You Should Know - Zacks Investment Research
Cardinal Health (CAH) Stock Moves -1.64%: What You Should Know - Yahoo Finance
Cardinal Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True? - Zacks Investment Research
Cardinal Health Sees Growth Normalize as Specialty, At-Home Investments Expand - Yahoo Finance
Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds - Yahoo Finance
Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did Better - Yahoo Finance
Cardinal Health stock dips despite solid fiscal 2026 earnings and upbeat analyst targets - ad-hoc-news.de
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue? - TradingView
Cardinal Health stock heads into the open after a 1.66 percent drop - ad-hoc-news.de
Cardinal Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Stan Wong's Past Picks: Amazon.com, Cardinal Health & DoorDash - BNN Bloomberg
Cardinal Health stock gains on solid analyst backing and steady price - ad-hoc-news.de
Cardinal Health at Wells Fargo conference: specialty growth drives outlook By Investing.com - Investing.com India
Cardinal Health at Wells Fargo conference: specialty growth drives outlook By Investing.com - Investing.com Canada
Cardinal Health Inc (CAH) 財務データ
収益
当期純利益
現金流量
EPS
Cardinal Health Inc (CAH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hollar Jason M. | Chief Executive Officer |
Aug 19 '26 |
Sale |
236.18 |
44,529 |
10,516,660 |
190,603 |
| Mary Scherer | Officer |
Aug 19 '26 |
Proposed Sale |
237.39 |
2,302 |
546,462 |
0 |
| WEITZMAN DEBORAH | CEO, PSS Segment |
Aug 18 '26 |
Sale |
235.45 |
7,354 |
1,731,524 |
77,901 |
| Alt Aaron E | Chief Financial Officer |
Aug 18 '26 |
Sale |
236.34 |
42,000 |
9,926,140 |
20,495 |
| Mayer Jessica L | Chief Legal/Compliance Officer |
Aug 18 '26 |
Sale |
236.19 |
29,436 |
6,952,485 |
33,076 |
| Greene Michelle D. | Chief Information Officer |
Aug 18 '26 |
Sale |
235.72 |
11,650 |
2,746,187 |
10,330 |
| Aaron Alt | Officer |
Aug 18 '26 |
Proposed Sale |
236.34 |
42,000 |
9,926,183 |
0 |
| Michelle Greene | Officer |
Aug 18 '26 |
Proposed Sale |
235.72 |
11,650 |
2,746,148 |
0 |
| Deborah Weitzman | Officer |
Aug 18 '26 |
Proposed Sale |
235.45 |
7,354 |
1,731,534 |
0 |
| Jessica Mayer | Officer |
Aug 18 '26 |
Proposed Sale |
236.19 |
29,436 |
6,952,441 |
0 |
0.78%
0.73%
大文字化:
|
ボリューム (24 時間):